Psilera Strengthens Board with Neuroscience

TAMPA –Psilera, a biotechnology company specializing in novel treatments for complex neurological disorders, has announced the addition of Dr. Magali Haas, M.D., Ph.D., to its Board of Directors. Dr. Haas, with an illustrious career spanning major roles at industry giants such as Janssen and Johnson & Johnson, as well as in biotechnology and mission-driven nonprofits, brings a rich background in neuroscience to the Psilera team.

Psilera’s CEO, Dr. Chris Witowski, expressed enthusiasm about Dr. Haas’s appointment, highlighting her alignment with the company’s mission. “We are thrilled to welcome Magali as an independent member of our Board of Directors. Her extensive background in neuroscience and experience translating early-stage research and clinical development align perfectly with our mission at Psilera,” said Witowski.

Dr. Haas is the Founder and Chair of Cohen Veterans Bioscience, a nonprofit organization dedicated to the advancement of brain health, particularly in the areas of post-traumatic stress (PTS) and traumatic brain injuries (TBI). Under her leadership as CEO & President for a decade, the organization has made significant strides in its field. Additionally, Dr. Haas’s initiative, the Brain Health Nexus, aims to enhance brain health globally through the development and adoption of a universal brain health index.

On her new role, Dr. Haas shared her enthusiasm for being part of Psilera’s journey. “Joining the board of Psilera provides a thrilling opportunity to be at the forefront of brain health research. I’m deeply impressed by their unique capabilities melding artificial intelligence and machine learning, a proprietary compound library, and a patient-centric ethos. I look forward to working with the leadership team and my board colleagues on transformative advancements for patients.”

Dr. Haas’s addition to the Board of Directors is a testament to Psilera’s commitment to advancing brain health and securing top-tier talent to guide its direction. With Dr. Haas’s expertise, Psilera is set to make significant progress in its mission to improve the lives of those suffering from brain-related conditions.